INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS COMPRISING SMALL NUCLEAR RNA (SNRNA) FOR TREATING GENETIC EPILEPSIES"

GENEVA, May 6 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2024/052593) for "COMPOSITIONS AND METHODS COMPRISING SMALL NUCLEAR RNA (SNRNA) FOR TREATING GENETIC EPILEPSIES" on Oct 23, 2024. With publication no. WO/2025/090628, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROTH, Daniela (c/o Locanabio, Inc.3545 John Hopkins CourtSuite 200San Diego, California 92121), BATRA, Ranjan (c/o Locanabio, Inc.3545 John Hopkins CourtSuite 200San Diego, C...